Results from the randomised-controlled trial indicated that ovarian cancer screening using CA125 (interpreted with the ROCA) and ultrasound scans in a general population sample of post-menopausal women show high sensitivity, specificity, acceptability, and compliance, but at initial reporting the mortality impact did not reach statistical significance [ 2 ].
← all excerpts
Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
1
—
—